Rebound of disease activity after fingolimod withdrawal: can we predict it?

被引：0
|
作者：
Dotor Garcia-Soto, J. [1 ]
Meca Lallana, V. [1 ]
Quintas, S. [1 ]
Aguirre, C. [1 ]
Sanchez, P. [1 ]
Vivancos, J. [1 ]
机构：
[1] Hosp La Princesa, Inst Invest Sanitaria, Dept Neurol, Demyelinating Dis, Madrid, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1761
引用
收藏
页码：927 / 928
页数：2
相关论文
共 50 条
  • [31] Opioid and Benzodiazepine Withdrawal Syndrome: Can We Predict and Prevent It?
    Ista, Erwin
    Tibboel, Dick
    van Dijk, Monique
    PEDIATRIC CRITICAL CARE MEDICINE, 2015, 16 (02) : 195 - 196
  • [32] REBOUND AFTER WITHDRAWAL OF NITROPRUSSIDE
    PAULSHOCK, BZ
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (18): : 1029 - 1029
  • [33] Can we predict aggressive disease?
    Young, A
    vanderHeijde, DMFM
    BAILLIERES CLINICAL RHEUMATOLOGY, 1997, 11 (01): : 27 - 48
  • [34] Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab
    Willis, M.
    Pearson, O.
    Illes, Z.
    Nielsen, C.
    Sejbaek, T.
    Duddy, M.
    Petheram, K.
    van Munster, C.
    Killestein, J.
    Uitdehaag, B.
    Malmestrom, C.
    Tallantyre, E.
    Robertson, N.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 664 - 665
  • [35] Disease activity during pregnancy after Fingolimod withdrawal due to planning a pregnancy in women with multiple sclerosis
    Hemat, Spalmai
    Houtchens, Maria
    Vidal-Jordana, Angela
    Guger, Michael
    Landi, Doriana
    D'Haeseleer, Miguel
    Annovazzi, Pietro
    Tintore, Mar
    Thiel, Sandra
    Gold, Ralf
    Hellwig, Kerstin
    NEUROLOGY, 2018, 90
  • [36] Fingolimod withdrawalRebound syndrome after the withdrawal of fingolimod: case report
    Reactions Weekly, 2019, 1750 (1) : 126 - 126
  • [37] CAN WE PREDICT SEIZURE RECURRENCE AFTER ANTIEPILEPTIC MEDICATION WITHDRAWAL FOLLOWING SEIZURE FREEDOM IN CHILDREN?
    Nickels, K.
    Wirrell, E.
    EPILEPSIA, 2009, 50 : 148 - 148
  • [38] Short term disease activity after switching from natalizumab to fingolimod does not predict long term fingolimod efficacy a retrospective study
    Coclitu, C.
    Riggi, F.
    Vaillant, M.
    Casez, O.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 341 - 341
  • [39] Disease activity during pregnancy after fingolimod withdrawal due to planning a pregnancy in women with multiple sclerosis.
    Hemat, S.
    Houtchens, M.
    Vidal-Jordana, A.
    Guger, M.
    Landi, D.
    D'Haeseleer, M.
    Annovazzi, P.
    Tintore, M.
    Thiel, S.
    Gold, R.
    Hellwig, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 74 - 75
  • [40] Diabetes after pancreaticoduodenectomy: can we predict it?
    Singh, Anand Narayan
    Pal, Sujoy
    Kilambi, Ragini
    Madhusudhan, Kumble Seetharama
    Dash, Nihar Ranjan
    Tandon, Nikhil
    Sahni, Peush
    JOURNAL OF SURGICAL RESEARCH, 2018, 227 : 211 - 219
12345